Articles From: BioAmber Announces Webcast of Fiscal Fourth Quarter and Full 2014 Financial Results to BioCryst to Announce 2014 Financial Results February 18 & Present at the 2015 Leerink Global Healthcare Conference


2015/2/23
MINNEAPOLIS, MN , Feb.
Sign-up for BioAmber Announces Webcast of Fiscal Fourth Quarter and Full 2014 Financial Results investment picks
2014/12/19
MINNEAPOLIS, MN , Dec.
Sign-up for BioAmber Refinances $25 Million Loan investment picks
2014/12/2
5 year supply agreement is with Oleon, a European leader in oleochemicals BioAmber bio-succinic acid is being used to produce bio-based lubricants Oleon is developing lubricants offering high performance, biodegradability and bio-based content Oleon operates 5 manufacturing facilities: four in Europe and one in Malaysia The addressable market for succinic acid in specialty lubricants is estimated to be $100 million MINNEAPOLIS , Dec.
Sign-up for BioAmber Signs Exclusive Supply Agreement for Bio-Succinic Acid in Lubricants investment picks
2015/2/4
Bioanalytical Systems, Inc. (NASDAQ:BASI) announced today that it will report financial results for the first quarter of fiscal 2015 ended December 31, 2014, prior to the market opening on Thursday, February 12, 2015.
Sign-up for Bioanalytical Systems to Release First Quarter Fiscal 2015 Results on Thursday, February 12, 2015; Conference Call & Webcast Set For 11:00 a.m. EST investment picks
2014/12/16
Bioanalytical Systems, Inc. (NASDAQ:BASI) announced today that it will now report fourth quarter and full year 2014 financial results prior to the market opening on Monday, December 22, 2014.
Sign-up for Bioanalytical Systems to Release Fourth Quarter Fiscal 2014 Results on Monday December 22, 2014; Conference Call & Webcast Set For 11:00 a.m. EST investment picks
2014/12/12
Bioanalytical Systems, Inc. (NASDAQ:BASI) will release financial results for the fourth quarter of fiscal 2014 ended September 30, 2014 at approximately 8:30 a.m. EST on Wednesday, December 17, 2014.
Sign-up for Bioanalytical Systems to Release Fourth Quarter Fiscal 2014 Results on Wednesday December 17, 2014; Conference Call & Webcast Set For 11:00 a.m. EST investment picks
2015/1/6
Bioanalytical Systems, Inc. (NASDAQ:BASI) announced today that Jacqueline Lemke, President and CEO, will present at the Noble Financial Capital Markets Eleventh Annual Equity Conference on Tuesday, January 20, 2015 at 11:00 a.m. EST in Room 1 at the Club Med in Sandpiper Bay, Florida.
Sign-up for Bioanalytical Systems, Inc. to Present at the 11th Annual Noble Financial Capital Markets Equity Conference Tuesday, January 20, 2015 at 11:00 a.m. EST investment picks
2015/2/17
TEL AVIV, Israel, Feb.
Sign-up for BioBlast Pharma Reports Fourth Quarter Financial Results investment picks
2015/2/24
TEL AVIV, Israel, Feb.
Sign-up for BioBlast Receives Notice of Allowance From USPTO Covering Cabaletta for the Treatment of OPMD investment picks
2015/1/8
SAN DIEGO and NASHVILLE, Tenn., Jan.
Sign-up for Biocept and Insight Genetics Collaborate to Advance Non-Small Cell Lung Cancer Diagnosis and Treatment investment picks
2014/12/3
SAN DIEGO, Dec.
Sign-up for Biocept Appoints Experienced Physician as Medical Director investment picks
2014/12/15
SAN DIEGO, Dec.
Sign-up for Biocept Expands Worldwide Microchannel Patent Protection to South Korea investment picks
2015/1/20
SAN DIEGO, Jan.
Sign-up for Biocept Introduces New Test for Patients With Non-Small Cell Lung Cancer investment picks
2015/1/7
SAN DIEGO, Jan.
Sign-up for Biocept to Present at the 8th Annual OneMedForum investment picks
2015/2/9
SAN DIEGO, Feb.
Sign-up for Biocept, Inc. Prices $10,000,000 Public Offering investment picks
2015/2/25
SAN DIEGO, Feb.
Sign-up for Biocept, Inc. Schedules Webcast and Conference Call for Fourth Quarter 2014 Financial Results investment picks
2015/1/7
SAN DIEGO, Jan.
Sign-up for Biocept's Proprietary Oncology Diagnostics to be Offered on America's Choice Provider Network investment picks
2014/12/15
RESEARCH TRIANGLE PARK, N.C., Dec.
Sign-up for BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX4430 for the Treatment of Hemorrhagic Fever Viruses investment picks
2014/12/23
RESEARCH TRIANGLE PARK, N.C., Dec.
Sign-up for BioCryst Announces Study Results for BCX4430 in a Non-Human Primate Model of Ebola Virus Infection investment picks
2014/12/18
RESEARCH TRIANGLE PARK, N.C., Dec.
Sign-up for BioCryst Initiates OPuS-2: A Clinical Trial of BCX4161 in Patients With Hereditary Angioedema investment picks
2015/1/5
RESEARCH TRIANGLE PARK, N.C., Jan.
Sign-up for BioCryst Pharmaceuticals Announces the Appointment of Lynne Powell as Chief Commercial Officer investment picks
2014/12/23
RESEARCH TRIANGLE PARK, N.C., Dec.
Sign-up for BioCryst Receives Orphan Drug Designation for BCX4161 for the Treatment of Hereditary Angioedema investment picks
2015/1/14
RESEARCH TRIANGLE PARK, N.C., Jan.
Sign-up for BioCryst Receives Positive Opinion on European Orphan Drug Designation for BCX4161 for the Treatment of Hereditary Angioedema investment picks
2015/2/18
RESEARCH TRIANGLE PARK, N.C., Feb.
Sign-up for BioCryst Reports Fourth Quarter & Full Year 2014 Financial Results investment picks
2015/1/14
BioCryst Pharmaceuticals Inc. shares (BCRX) surged more than 5% in premarket trade, after the company said it received a positive opinion on European orphan drug designation for its treatment for hereditary angioedema.
Sign-up for BioCryst shares rally on positive opinion from Europe for angioedema drug investment picks
2015/2/5
RESEARCH TRIANGLE PARK, N.C., Feb.
Sign-up for BioCryst to Announce 2014 Financial Results February 18 & Present at the 2015 Leerink Global Healthcare Conference investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: BioAmber Announces Webcast of Fiscal Fourth Quarter and Full 2014 Financial Results to BioCryst to Announce 2014 Financial Results February 18 & Present at the 2015 Leerink Global Healthcare Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent